Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST002615)

RP NEGATIVE ION MODE (Analysis AN004287)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11
hypoxanthine	ME622887	0.55	1.30	2.45	0.78	0.29	0.59	0.48	0.63	0.36	0.78	1.92
ADP-ribose	ME622871	0.67	0.80	2.87	0.81	0.67	0.77	0.55	0.79	0.62	0.62	0.69
guanosine	ME622885	0.77	1.00	3.03	0.80	0.50	0.97	0.59	0.52	0.48	0.50	0.62
NADH	ME622891	1.36	0.51	0.86	1.44	0.73	1.23	0.91	1.27	0.70	1.24	0.82
ZMP	ME622904	1.04	0.41	0.78	1.52	0.47	1.66	0.80	1.46	0.85	1.41	0.74
NaMN	ME622894	0.86	1.05	1.73	0.80	0.92	0.71	1.20	0.41	0.73	0.61	1.53
NMN	ME622895	0.73	1.36	1.49	0.71	0.98	0.71	0.88	0.83	0.76	0.84	1.41
GMP	ME622883	0.85	1.18	1.49	0.78	1.11	0.96	0.82	0.65	1.03	0.73	1.10
CMP	ME622876	0.78	1.11	1.74	0.83	0.94	0.89	0.82	0.69	0.93	0.83	0.99
NADP+	ME622892	0.87	1.19	1.55	0.77	0.93	0.80	0.99	0.77	0.93	0.82	1.05
AMP	ME622873	0.98	1.24	1.91	0.95	0.80	1.12	0.58	0.60	0.63	0.61	1.04
guanine	ME622886	0.98	0.94	2.02	1.16	0.52	1.19	0.64	0.95	0.54	0.50	0.97
S-AMP	ME622898	1.10	0.93	1.95	1.15	0.49	1.25	0.71	0.63	0.65	0.71	0.87
UMP	ME622901	0.96	0.94	2.14	0.93	0.63	1.05	0.74	0.67	0.71	0.62	0.94
5^-methylthioadenosine	ME622889	0.84	0.75	1.50	0.91	0.90	1.04	0.97	1.16	0.88	0.96	0.79
AICAR	ME622872	0.89	0.93	1.44	1.44	0.56	1.45	0.87	0.77	0.47	1.04	0.76
S-adenosylhomocysteine	ME622897	1.08	0.72	1.52	1.01	0.59	1.42	0.70	1.05	0.66	1.08	0.87
IMP	ME622888	0.62	1.40	0.65	0.67	1.58	0.86	1.16	0.65	1.51	0.86	1.26
ATP	ME622874	0.54	1.48	0.60	0.63	1.49	0.61	1.19	0.82	1.46	0.96	1.46
dATP	ME622878	0.50	1.28	0.81	0.66	1.50	0.55	1.13	0.79	1.52	0.91	1.47
dCTP	ME622879	0.65	1.18	0.70	0.80	1.50	0.74	1.25	0.82	1.40	0.80	1.33
PRPP	ME622896	0.64	1.36	0.60	0.83	1.37	0.62	1.33	0.73	1.36	0.92	1.48
UTP	ME622902	0.59	0.98	0.11	0.85	1.59	0.61	1.57	1.13	1.51	1.23	1.36
CTP	ME622877	0.56	1.31	0.24	0.70	1.80	0.55	1.36	1.00	1.55	1.11	1.27
GTP	ME622884	0.55	1.53	0.25	0.70	1.60	0.64	1.35	0.87	1.57	0.99	1.40
GDP	ME622881	0.80	1.35	0.83	0.86	1.16	0.95	1.08	0.85	1.24	0.77	1.22
ADP	ME622870	0.77	1.17	1.10	0.79	1.13	0.87	1.02	0.80	1.17	0.88	1.24
UDP-galactose	ME622900	0.81	1.18	1.13	0.81	1.08	0.94	1.09	0.85	1.08	0.88	1.06
XMP	ME622903	1.00	1.24	0.89	1.16	0.86	0.92	0.89	0.93	0.90	1.02	1.26
CDP	ME622875	0.87	1.21	0.77	0.96	1.11	0.96	1.02	1.12	1.07	0.93	1.10
adenine	ME622869	0.95	1.03	1.06	0.90	1.02	0.96	0.96	1.08	0.96	1.07	0.97
NAD+	ME622890	0.97	1.00	1.14	0.98	1.01	0.96	0.92	0.98	0.98	1.01	0.97
GDP-mannose	ME622882	1.04	0.86	0.94	1.08	0.85	0.98	0.83	1.26	0.91	1.34	0.95
dTTP	ME622880	0.79	0.95	0.64	1.07	1.26	0.93	1.05	1.01	1.14	1.26	1.10
NADPH	ME622893	1.05	0.75	0.62	1.13	1.08	1.06	1.09	1.27	1.13	1.17	0.89
UDP	ME622899	0.89	1.05	0.42	1.11	1.03	1.06	1.22	1.25	1.11	1.04	1.15

Factors:

F1	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Female
F2	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Male
F3	Group:QC-ExternalStandard \| Timepoint:0 hour \| Sex:-
F4	Group:Training \| Timepoint:1 week of training or control time \| Sex:Female
F5	Group:Training \| Timepoint:1 week of training or control time \| Sex:Male
F6	Group:Training \| Timepoint:2 weeks of training \| Sex:Female
F7	Group:Training \| Timepoint:2 weeks of training \| Sex:Male
F8	Group:Training \| Timepoint:4 weeks of training \| Sex:Female
F9	Group:Training \| Timepoint:4 weeks of training \| Sex:Male
F10	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Female
F11	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Male

Data matrix